Format

Send to

Choose Destination
See comment in PubMed Commons below
Int J Hyperthermia. 2008 Feb;24(1):97-110. doi: 10.1080/02656730701824406.

Current status of antivascular therapy and targeted treatment in the clinic.

Author information

  • 1Institute of Medicine, University of Bergen Section of Oncology, Bergen, Norway. olav.dahl@helse-bergen.no

Abstract

Antivascular and targeted therapy are now an integrated part of the treatment of myelogenous leukemias, GIST tumours, B-cell lymphomas and breast cancer. In various malignancies improved responses and prolongation of survival for several months is regularly reported. The progress in this field is relevant for hyperthermia. Heat has among other effects documented antivascular effects, and can be considered as one of the established methods in the field based on several randomised phase III studies. Hyperthermia should be considered for combination with other antiangiogenic agents.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Taylor & Francis
    Loading ...
    Write to the Help Desk